Literature DB >> 20704674

Sensory disturbances in complex regional pain syndrome: clinical observations, autonomic interactions, and possible mechanisms.

Peter D Drummond1.   

Abstract

OBJECTIVE: To review mechanisms that might contribute to sensory disturbances and sympathetically-maintained pain in complex regional pain syndrome (CRPS).
BACKGROUND: CRPS is associated with a range of sensory and autonomic abnormalities. In a subpopulation of patients, sympathetic nervous system arousal and intradermal injection of adrenergic agonists intensify pain.
RESULTS: Mechanisms responsible for sensory abnormalities in CRPS include sensitization of primary afferent nociceptors and spinothalamic tract neurons, disinhibition of central nociceptive neurons, and reorganization of thalamo-cortical somatosensory maps. Proposed mechanisms of sympathetically-maintained pain include adrenergic excitation of sensitized nociceptors in the CRPS-affected limb, and interaction between processes within the central nervous system that modulate nociception and emotional responses. Central mechanisms could involve adrenergic facilitation of nociceptive transmission in the dorsal horn or thalamus, and/or depletion of bulbo-spinal opioids or tolerance to their effects.
CONCLUSIONS: Sympathetic neural activity might contribute to pain and sensory disturbances in CRPS by feeding into nociceptive circuits at the site of injury or elsewhere in the CRPS-affected limb, within the dorsal horn, or via thalamo-cortical projections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20704674     DOI: 10.1111/j.1526-4637.2010.00912.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  9 in total

Review 1.  Clinical features and pathophysiology of complex regional pain syndrome.

Authors:  Johan Marinus; G Lorimer Moseley; Frank Birklein; Ralf Baron; Christian Maihöfner; Wade S Kingery; Jacobus J van Hilten
Journal:  Lancet Neurol       Date:  2011-07       Impact factor: 44.182

2.  Concomitant Glomus Tumor with CRPS in the Hand.

Authors:  Hyeong Jun Jeong; Chan Mi Kim; Duck Mi Yoon; Kyung Bong Yoon
Journal:  Korean J Pain       Date:  2013-07-01

3.  Algodystrophy: complex regional pain syndrome and incomplete forms.

Authors:  Stefano Giannotti; Vanna Bottai; Giacomo Dell'Osso; Giulia Bugelli; Fabio Celli; Niki Cazzella; Giulio Guido
Journal:  Clin Cases Miner Bone Metab       Date:  2016-05-11

Review 4.  Imaging and clinical evidence of sensorimotor problems in CRPS: utilizing novel treatment approaches.

Authors:  Jacqueline Bailey; Sara Nelson; Jenny Lewis; Candida S McCabe
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-11       Impact factor: 4.147

5.  A possible role of the locus coeruleus in complex regional pain syndrome.

Authors:  Peter D Drummond
Journal:  Front Integr Neurosci       Date:  2012-11-08

6.  Synaptic conversion of chloride-dependent synapses in spinal nociceptive circuits: roles in neuropathic pain.

Authors:  Mark S Cooper; Adam S Przebinda
Journal:  Pain Res Treat       Date:  2011-06-15

7.  Implications of the putamen in pain and motor deficits in complex regional pain syndrome.

Authors:  Monica Azqueta-Gavaldon; Andrew M Youssef; Claudia Storz; Jordan Lemme; Heike Schulte-Göcking; Lino Becerra; Shahnaz C Azad; Anselm Reiners; Birgit Ertl-Wagner; David Borsook; Jaymin Upadhyay; Eduard Kraft
Journal:  Pain       Date:  2020-03       Impact factor: 7.926

8.  Peripheral and Central Metabolites Affecting Depression, Anxiety, Suicidal Ideation, and Anger in Complex Regional Pain Syndrome Patients Using a Magnetic Resonance Spectroscopy: A Pilot Study.

Authors:  Ye-Ha Jung; Hyeonjin Kim; So Yeon Jeon; Jeong Min Kwon; Won Joon Lee; Joon Hwan Jang; Dasom Lee; Yoonji Lee; Do-Hyung Kang
Journal:  Psychiatry Investig       Date:  2018-09-17       Impact factor: 2.505

Review 9.  Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States.

Authors:  Daniel B Lowy; Preet G S Makker; Gila Moalem-Taylor
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.